Fox Run Management L.L.C. Buys New Shares in Danaher Corporation $DHR

Key Points

• Fox Run Management L.L.C. invested $649,000 in Danaher Corporation, acquiring 3,164 shares in the first quarter of the year.
• Overall, about 79.05% of Danaher’s stock is held by institutional investors, with several hedge funds increasing their stakes recently.
• Analysts have a consensus rating of "Moderate Buy" for Danaher, with an average target price of $247.61 following various reassessments of the stock's market value.

Fox Run Management L.L.C. purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,164 shares of the conglomerate's stock, valued at approximately $649,000.

Several other large investors also recently modified their holdings of the stock. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher in the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC grew its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after acquiring an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 3.4%

Shares of NYSE DHR traded down $7.1650 during mid-day trading on Thursday, reaching $204.2350. 1,853,456 shares of the company's stock were exchanged, compared to its average volume of 4,217,296. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $200.46 and a 200 day simple moving average of $199.62. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The firm has a market capitalization of $146.24 billion, a price-to-earnings ratio of 43.53, a PEG ratio of 2.96 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's revenue was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on DHR shares. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. TD Cowen lifted their target price on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research note on Wednesday, April 23rd. Evercore ISI decreased their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Finally, Robert W. Baird upped their target price on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research report on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.